<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01283555</url>
  </required_header>
  <id_info>
    <org_study_id>PATH HS-522</org_study_id>
    <nct_id>NCT01283555</nct_id>
  </id_info>
  <brief_title>Comparative Safety Study of Two Vaginal Applicators With Tenofovir</brief_title>
  <official_title>Comparative Safety Study of Pre-Filled Plastic and User-Filled Paper Vaginal Applicators With Candidate Microbicide, Tenofovir</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PATH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CONRAD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Profamilia, Santo Domingo, DR</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>PATH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare the effect of two vaginal applicators,
      delivering the candidate microbicide Tenofovir, on symptoms and signs of irritation of the
      external genitalia, cervix and vagina as seen on colposcopy after seven days of twice daily
      use.

      The secondary objectives are to:

        1. Evaluate and compare the dosing accuracy and precision of the user-filled applicator and
           pre-filled applicator with the candidate microbicide, Tenofovir.

        2. Compare the acceptability of the user-filled applicator with the pre-filled applicator.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Colposcopic Findings (Baseline and After One Week of Product Use)</measure>
    <time_frame>7 days</time_frame>
    <description>Comparison of colposcopic findings between baseline visits and after one week of twice-daily application of Tenofovir 1% gel with either a user-filled or prefilled applicator</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Filled Volume</measure>
    <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
    <description>At each dose delivery visit, the applicator was weighed, prior to vaginal insertion. For the user-filled applicator, the participant handed the applicator to the investigator after filling with gel from the multidose tube. The applicator was then weighed and returned to the participant for insertion. For the prefilled applicator, the participant inserted the plunger into the barrel, and then handed the applicator to the investigator for weighing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Filling Precision (5% Range)</measure>
    <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
    <description>A 5% range was calculated around the average filled volumes to determine how many applicators were filled within this range (+/-5% of average volume)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Filling Precision (10% Range)</measure>
    <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
    <description>A 10% range was calculated around the average filled volumes to determine how many applicators were filled within this range (+/-10% of average volume)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Filling Accuracy (% of Target Dose)</measure>
    <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
    <description>The target dose for Tenofovir gel in this study was 4.0ml, which is the volume of Tenofovir being used in current microbicide clinical trials. The filled volume for each applicator was compared with the intended target dose of 4.0ml.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosing Volume (Expressed Volume)</measure>
    <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
    <description>At each dose delivery visit, the applicator was weighed prior to vaginal insertion and after use. The volume of gel expressed was measured using the following data: weight of filled applicator, weight of emptied applicator, the average weight of an empty applicator, and gel density.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosing Precision, 5% (Expressed Volume)</measure>
    <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
    <description>A 5% range was calculated around the average expressed volume of 3.83ml to determine how many applicators delivered a dose within this range (+/-5% of average volume)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosing Precision, 10% (Expressed Volume)</measure>
    <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
    <description>A 10% range was calculated around the average expressed volume of 3.83ml to determine how many applicators delivered a dose within this range (+/-10% of average volume)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosing Accuracy (% of Target Dose Delivered)</measure>
    <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
    <description>The target dose for Tenofovir gel in this study was 4.0ml, which is the volume of Tenofovir being used in current microbicide clinical trials. The average dose delivered for each applicator was compared with the intended target dose of 4.0ml.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Applicator Easy to Fill</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked to describe the process of filling the user-filled applicator.
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.
Since &quot;ease of filling&quot; only applies to the user-filled applicator, this question was not applicable for the prefilled applicator.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Respondents Reporting Confidence With Filling the User-filled Applicator</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked when using the user-filled applicator, how confident did they feel that they at inserted the correct amount of gel into the applicator.
Response categories included &quot;very confident&quot;, &quot;confident&quot;, and &quot;not confident&quot;.
(Note: this question does not apply to the prefilled applicator.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons Given by Participants for Knowing When the Applicator Was Filled Correctly</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked how did they know when the applicator was filled correctly (that is, with the right amount of gel). More than one answer was allowed.
Response categories included &quot;plunger automatically stopped&quot;, &quot;the 'FULL' line was reached&quot;, and &quot;other&quot;.
Note: this question does not apply to the prefilled applicator.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Applicator Easy to Insert</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked to describe the insertion of the applicator into the vagina for each applicator (user-filled and prefilled).
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting That the Gel Was Easy to Dispense</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked to describe the dispensing of the gel into the vagina with each applicator (user-filled and prefilled).
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Applicator Preference (User-filled or Prefilled) Across a Variety of Factors</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked about their preference for either the user-filled or prefilled applicator with regard to several use factors as well as in relation to disposal, storage, and overall comfort and preference.
Response categories included &quot;user-filled&quot;, &quot;prefilled&quot;, and &quot;same&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting That Applicator Was Comfortable to Use</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked to describe the comfort of use for each applicator type(user-filled and prefilled).
Response categories included &quot;comfortable&quot;, &quot;neutral&quot;, and &quot;uncomfortable&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Suggestions Regarding Ease of Use or Comfort</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked if they could suggest ways that would make each applicator easier or more comfortable to use. Response categories were &quot;yes&quot; and &quot;no&quot;. If yes, participants were asked to describe how they would make the applicator easier and/or more comfortable to use.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting That the Instructions for Use Were Helpful</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>For each applicator type, participants were asked if the instructions were helpful to you.
Response categories were &quot;yes&quot; and &quot;no&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting That Both Applicators Were Acceptable</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked if both applicators were acceptable to them. Responses were either &quot;yes&quot; or &quot;no&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting That the Cost of the Applicator Would Influence Their Choice of Applicator</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked if the cost of the applicator would influence their choice of applicator.
Response categories were &quot;yes&quot;, &quot;no&quot;, and &quot;maybe&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting That They Would Use the User-filled Applicator in the Future if it Came With a Gel for HIV Prevention</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked if they would use the user-filled applicator in the future if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting That They Would Not Want to Use the User-filled Applicator in the Future if it Came With a Gel for HIV Prevention</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked if there were any reasons that they would not want to use this user-filled applicator in the future if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting That They Would Recommend the User-filled Applicator for HIV Prevention</measure>
    <time_frame>Final study visit (after completing both study arms)</time_frame>
    <description>Participants were asked if they would recommend the user-filled applicator to other women if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Microbicide Applicator</condition>
  <arm_group>
    <arm_group_label>User-Filled Applicator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Prefilled applicator</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tenofovir</intervention_name>
    <description>Delivered using prefilled and user-filled applicator</description>
    <arm_group_label>User-Filled Applicator</arm_group_label>
    <arm_group_label>Prefilled applicator</arm_group_label>
    <other_name>TFV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Age 18 to 50, inclusive

          -  Pre-menopausal

          -  In good health as reported by individual

          -  Have regular menstrual cycles (24 to 35 days)

          -  Low risk for sexually transmitted infections (only one sexual partner in the last
             three months)

          -  Not pregnant or at risk of pregnancy (must either have had a tubal ligation, or
             currently be using a hormonal method of contraception)

          -  Negative on a urine pregnancy test

          -  Willing to abstain from sexual intercourse and masturbation during two 7-day periods
             when applicators are being used

          -  Willing to abstain from use of vaginal products during course of study (including
             douching, use of vaginal applicators for medication, lubrication, sex toys, other)

          -  Willing to follow procedural requirements of study

          -  Willing and able to provide informed consent for study participation

          -  Willing to provide investigator with phone number or address where she can be reached
             during the study

        Exclusion Criteria:

          -  History of hysterectomy

          -  Pregnancy or within two months of last pregnancy outcome (delivery, spontaneous or
             induced abortion, medical or surgical management of ectopic pregnancy)

          -  Post-menopausal

          -  Breastfeeding

          -  Use of an intra-uterine device (IUD), cervical caps or diaphragm for contraceptive
             purposes

          -  Diagnosis or treatment for a sexually transmitted disease within the past 30 days;

          -  More than one sexual partner in the last 3 months

          -  Has had surgery on the external genitalia, vagina, or cervix within the past 3 months;

          -  Current or past use of any anti-retroviral therapies including but not limited to
             systemic Tenofovir (VireadÂ®)

          -  Current or anticipated use of drugs on a daily basis that may reduce renal function
             (e.g. acyclovir or ibuprofen) or liver function (e.g. Tylenol)

          -  HIV positive at time of screening

          -  Hepatitis B surface antigen (HBsAg) positive at time of screening

          -  Positive test results for Neisseria gonorrhea, Chlamydia trachomatis, or Trichomonas
             vaginalis at time of screening.

          -  At baseline colposcopic exam (Visit 2), findings involving disruption of epithelium
             with disruption of blood vessels or deep disruption of epithelium alone. Any area of
             epithelium with bleeding will be considered deeply disrupted.

          -  Any abnormal finding on colposcopic exams which in the opinion of the investigator,
             precludes participation in the study

          -  At baseline exams, clinical symptoms or signs of vaginitis or vulvitis confirmed by a
             wet mount exam of the discharge. Note: If vaginitis or vulvitis is present at either
             baseline exam (visits 2 or 10), volunteer will be treated and rescheduled for new
             baseline exam one week after application of last treatment dose. If signs or symptoms
             are still present at the rescheduled baseline exam for Visit 2, the volunteer will not
             be enrolled into study. If signs or symptoms are still present at the rescheduled
             baseline exam for Visit 10, the volunteer will be discontinued from the study.

          -  Serum chemistry (glucose, creatinine, bilirubin, AST [aspartate aminotransferase] and
             ALT [alanine transaminase]) not within normal expected levels according to the
             specifications of the local laboratory.

          -  Hemoglobin, hematocrit and total white blood cell not within 15 % of lower and upper
             limit normal levels according to the specifications of the local laboratory.

          -  Participation in any other research study in the 30 days prior to screening and/or
             plans to participate in any other research study during the entire study duration.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivian Brache</last_name>
    <role>Principal Investigator</role>
    <affiliation>Profamilia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinica Profamilia</name>
      <address>
        <city>Santo Domingo</city>
        <zip>10401</zip>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Dominican Republic</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2011</study_first_submitted>
  <study_first_submitted_qc>January 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2011</study_first_posted>
  <results_first_submitted>February 16, 2012</results_first_submitted>
  <results_first_submitted_qc>May 21, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 22, 2012</results_first_posted>
  <last_update_submitted>July 10, 2012</last_update_submitted>
  <last_update_submitted_qc>July 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Microbicide, Applicator, Safety</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tenofovir</mesh_term>
    <mesh_term>Anti-Infective Agents</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment began on 26 January 2011 and ended on 10 March 2011. Recruitment was done at Clinica Profamilia, Santo Domingo, Dominican Republic. Healthy women, 18 to 50 years of age (inclusive), who attended the clinic for health care, who were not at risk for pregnancy, and at low risk of sexually transmitted infection were informed of the study.</recruitment_details>
      <pre_assignment_details>25 were enrolled in this study which used a cross-over design. Participants were randomized to order of applicator use.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>User-Filled Applicator First, Then Prefilled</title>
          <description>User-filled paper applicator (filled using a tube of Tenofovir 1% gel)used twice daily in first intervention period and prefilled applicator used twice daily in second intervention period (after washout period)</description>
        </group>
        <group group_id="P2">
          <title>Prefilled Applicator First, Then User-filled</title>
          <description>Plastic applicator (prefilled with Tenofovir 1% gel) used twice daily in first intervention period and user-filled applicator used twice daily in second intervention period (after washout period)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout Period of at Least 21 Days</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Entire Study Population</title>
          <description>Includes groups randomized to use the prefilled applicator first and the user-filled applicator first.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Dominican Republic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Filled Volume</title>
        <description>At each dose delivery visit, the applicator was weighed, prior to vaginal insertion. For the user-filled applicator, the participant handed the applicator to the investigator after filling with gel from the multidose tube. The applicator was then weighed and returned to the participant for insertion. For the prefilled applicator, the participant inserted the plunger into the barrel, and then handed the applicator to the investigator for weighing.</description>
        <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
        <population>Per protocol all participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Filled Volume</title>
          <description>At each dose delivery visit, the applicator was weighed, prior to vaginal insertion. For the user-filled applicator, the participant handed the applicator to the investigator after filling with gel from the multidose tube. The applicator was then weighed and returned to the participant for insertion. For the prefilled applicator, the participant inserted the plunger into the barrel, and then handed the applicator to the investigator for weighing.</description>
          <population>Per protocol all participants were included in the analysis.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>filled volume</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.22" spread=".24"/>
                    <measurement group_id="O2" value="4.11" spread=".07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Filling Precision (5% Range)</title>
        <description>A 5% range was calculated around the average filled volumes to determine how many applicators were filled within this range (+/-5% of average volume)</description>
        <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
        <population>Per protocol all participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Filling Precision (5% Range)</title>
          <description>A 5% range was calculated around the average filled volumes to determine how many applicators were filled within this range (+/-5% of average volume)</description>
          <population>Per protocol all participants were included in the analysis.</population>
          <units>doses</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>volume of filled applicator</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                    <measurement group_id="O2" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Filling Precision (10% Range)</title>
        <description>A 10% range was calculated around the average filled volumes to determine how many applicators were filled within this range (+/-10% of average volume)</description>
        <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
        <population>Per protocol all participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Filling Precision (10% Range)</title>
          <description>A 10% range was calculated around the average filled volumes to determine how many applicators were filled within this range (+/-10% of average volume)</description>
          <population>Per protocol all participants were included in the analysis.</population>
          <units>doses</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>volume of filled applicators</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                    <measurement group_id="O2" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Filling Accuracy (% of Target Dose)</title>
        <description>The target dose for Tenofovir gel in this study was 4.0ml, which is the volume of Tenofovir being used in current microbicide clinical trials. The filled volume for each applicator was compared with the intended target dose of 4.0ml.</description>
        <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
        <population>Per protocol all participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Filling Accuracy (% of Target Dose)</title>
          <description>The target dose for Tenofovir gel in this study was 4.0ml, which is the volume of Tenofovir being used in current microbicide clinical trials. The filled volume for each applicator was compared with the intended target dose of 4.0ml.</description>
          <population>Per protocol all participants were included in the analysis.</population>
          <units>% of target dose filled into applicator</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>volume of filled applicator</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.5"/>
                    <measurement group_id="O2" value="102.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dosing Volume (Expressed Volume)</title>
        <description>At each dose delivery visit, the applicator was weighed prior to vaginal insertion and after use. The volume of gel expressed was measured using the following data: weight of filled applicator, weight of emptied applicator, the average weight of an empty applicator, and gel density.</description>
        <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
        <population>Per protocol, all participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Dosing Volume (Expressed Volume)</title>
          <description>At each dose delivery visit, the applicator was weighed prior to vaginal insertion and after use. The volume of gel expressed was measured using the following data: weight of filled applicator, weight of emptied applicator, the average weight of an empty applicator, and gel density.</description>
          <population>Per protocol, all participants were included in the analysis.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>dosing volume</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.83" spread=".35"/>
                    <measurement group_id="O2" value="NA">As a result of an error in the interpretation of the user instructions, the dose delivery data for the prefilled applicator was not valid.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dosing Precision, 5% (Expressed Volume)</title>
        <description>A 5% range was calculated around the average expressed volume of 3.83ml to determine how many applicators delivered a dose within this range (+/-5% of average volume)</description>
        <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
        <population>Per protocol all participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Dosing Precision, 5% (Expressed Volume)</title>
          <description>A 5% range was calculated around the average expressed volume of 3.83ml to determine how many applicators delivered a dose within this range (+/-5% of average volume)</description>
          <population>Per protocol all participants were included in the analysis.</population>
          <units>doses</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>dosing volume</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="NA">As a result of an error in the interpretation of the user instructions, the dose delivery data for the prefilled applicator was not valid.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dosing Precision, 10% (Expressed Volume)</title>
        <description>A 10% range was calculated around the average expressed volume of 3.83ml to determine how many applicators delivered a dose within this range (+/-10% of average volume)</description>
        <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
        <population>Per protocol all participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Dosing Precision, 10% (Expressed Volume)</title>
          <description>A 10% range was calculated around the average expressed volume of 3.83ml to determine how many applicators delivered a dose within this range (+/-10% of average volume)</description>
          <population>Per protocol all participants were included in the analysis.</population>
          <units>doses</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>dosing volume</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                    <measurement group_id="O2" value="NA">As a result of an error in the interpretation of the user instructions, the dose delivery data for the prefilled applicator was not valid.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dosing Accuracy (% of Target Dose Delivered)</title>
        <description>The target dose for Tenofovir gel in this study was 4.0ml, which is the volume of Tenofovir being used in current microbicide clinical trials. The average dose delivered for each applicator was compared with the intended target dose of 4.0ml.</description>
        <time_frame>3 dose delivery measurements during 1 week of product use</time_frame>
        <population>Per protocol all participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Dosing Accuracy (% of Target Dose Delivered)</title>
          <description>The target dose for Tenofovir gel in this study was 4.0ml, which is the volume of Tenofovir being used in current microbicide clinical trials. The average dose delivered for each applicator was compared with the intended target dose of 4.0ml.</description>
          <population>Per protocol all participants were included in the analysis.</population>
          <units>percent of target dose delivered</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>dosing volume</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                    <measurement group_id="O2" value="NA">As a result of an error in the interpretation of the user instructions, the dose delivery data for the prefilled applicator was not valid.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Applicator Easy to Fill</title>
        <description>Participants were asked to describe the process of filling the user-filled applicator.
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.
Since &quot;ease of filling&quot; only applies to the user-filled applicator, this question was not applicable for the prefilled applicator.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Applicator Easy to Fill</title>
          <description>Participants were asked to describe the process of filling the user-filled applicator.
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.
Since &quot;ease of filling&quot; only applies to the user-filled applicator, this question was not applicable for the prefilled applicator.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Easy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderately difficult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difficult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Respondents Reporting Confidence With Filling the User-filled Applicator</title>
        <description>Participants were asked when using the user-filled applicator, how confident did they feel that they at inserted the correct amount of gel into the applicator.
Response categories included &quot;very confident&quot;, &quot;confident&quot;, and &quot;not confident&quot;.
(Note: this question does not apply to the prefilled applicator.)</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Respondents Reporting Confidence With Filling the User-filled Applicator</title>
          <description>Participants were asked when using the user-filled applicator, how confident did they feel that they at inserted the correct amount of gel into the applicator.
Response categories included &quot;very confident&quot;, &quot;confident&quot;, and &quot;not confident&quot;.
(Note: this question does not apply to the prefilled applicator.)</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Very confident</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Confident</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not confident</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reasons Given by Participants for Knowing When the Applicator Was Filled Correctly</title>
        <description>Participants were asked how did they know when the applicator was filled correctly (that is, with the right amount of gel). More than one answer was allowed.
Response categories included &quot;plunger automatically stopped&quot;, &quot;the 'FULL' line was reached&quot;, and &quot;other&quot;.
Note: this question does not apply to the prefilled applicator.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis. Each participant could identify multiple reasons. As a result, the number of units analyzed is greater than the number of participants.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Reasons Given by Participants for Knowing When the Applicator Was Filled Correctly</title>
          <description>Participants were asked how did they know when the applicator was filled correctly (that is, with the right amount of gel). More than one answer was allowed.
Response categories included &quot;plunger automatically stopped&quot;, &quot;the 'FULL' line was reached&quot;, and &quot;other&quot;.
Note: this question does not apply to the prefilled applicator.</description>
          <population>All participants were included in the analysis. Each participant could identify multiple reasons. As a result, the number of units analyzed is greater than the number of participants.</population>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>responses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Plunger automatically stopped</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>The fill line/arrow was reached</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Applicator Easy to Insert</title>
        <description>Participants were asked to describe the insertion of the applicator into the vagina for each applicator (user-filled and prefilled).
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Applicator Easy to Insert</title>
          <description>Participants were asked to describe the insertion of the applicator into the vagina for each applicator (user-filled and prefilled).
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Easy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderately difficult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difficult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting That the Gel Was Easy to Dispense</title>
        <description>Participants were asked to describe the dispensing of the gel into the vagina with each applicator (user-filled and prefilled).
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting That the Gel Was Easy to Dispense</title>
          <description>Participants were asked to describe the dispensing of the gel into the vagina with each applicator (user-filled and prefilled).
Response categories included &quot;easy&quot;, &quot;moderately difficult&quot;, and &quot;difficult&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Easy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderately difficult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difficult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Applicator Preference (User-filled or Prefilled) Across a Variety of Factors</title>
        <description>Participants were asked about their preference for either the user-filled or prefilled applicator with regard to several use factors as well as in relation to disposal, storage, and overall comfort and preference.
Response categories included &quot;user-filled&quot;, &quot;prefilled&quot;, and &quot;same&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
          <group group_id="O3">
            <title>Same</title>
            <description>no preference between user-filled or prefilled applicator</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Applicator Preference (User-filled or Prefilled) Across a Variety of Factors</title>
          <description>Participants were asked about their preference for either the user-filled or prefilled applicator with regard to several use factors as well as in relation to disposal, storage, and overall comfort and preference.
Response categories included &quot;user-filled&quot;, &quot;prefilled&quot;, and &quot;same&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>responses</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ease of use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of dispensing gel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of disposal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of storage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall applicator preference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting That Applicator Was Comfortable to Use</title>
        <description>Participants were asked to describe the comfort of use for each applicator type(user-filled and prefilled).
Response categories included &quot;comfortable&quot;, &quot;neutral&quot;, and &quot;uncomfortable&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting That Applicator Was Comfortable to Use</title>
          <description>Participants were asked to describe the comfort of use for each applicator type(user-filled and prefilled).
Response categories included &quot;comfortable&quot;, &quot;neutral&quot;, and &quot;uncomfortable&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Comfortable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutral</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uncomfortable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Suggestions Regarding Ease of Use or Comfort</title>
        <description>Participants were asked if they could suggest ways that would make each applicator easier or more comfortable to use. Response categories were &quot;yes&quot; and &quot;no&quot;. If yes, participants were asked to describe how they would make the applicator easier and/or more comfortable to use.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Suggestions Regarding Ease of Use or Comfort</title>
          <description>Participants were asked if they could suggest ways that would make each applicator easier or more comfortable to use. Response categories were &quot;yes&quot; and &quot;no&quot;. If yes, participants were asked to describe how they would make the applicator easier and/or more comfortable to use.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting That the Instructions for Use Were Helpful</title>
        <description>For each applicator type, participants were asked if the instructions were helpful to you.
Response categories were &quot;yes&quot; and &quot;no&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>User-Filled Applicator</title>
            <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
          </group>
          <group group_id="O2">
            <title>Prefilled Applicator</title>
            <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting That the Instructions for Use Were Helpful</title>
          <description>For each applicator type, participants were asked if the instructions were helpful to you.
Response categories were &quot;yes&quot; and &quot;no&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting That Both Applicators Were Acceptable</title>
        <description>Participants were asked if both applicators were acceptable to them. Responses were either &quot;yes&quot; or &quot;no&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Entire Study Population</title>
            <description>Includes groups randomized to use the prefilled applicator first and the user-filled applicator first.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting That Both Applicators Were Acceptable</title>
          <description>Participants were asked if both applicators were acceptable to them. Responses were either &quot;yes&quot; or &quot;no&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting That the Cost of the Applicator Would Influence Their Choice of Applicator</title>
        <description>Participants were asked if the cost of the applicator would influence their choice of applicator.
Response categories were &quot;yes&quot;, &quot;no&quot;, and &quot;maybe&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Entire Study Population</title>
            <description>Includes groups randomized to use the prefilled applicator first and the user-filled applicator first.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting That the Cost of the Applicator Would Influence Their Choice of Applicator</title>
          <description>Participants were asked if the cost of the applicator would influence their choice of applicator.
Response categories were &quot;yes&quot;, &quot;no&quot;, and &quot;maybe&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Maybe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Colposcopic Findings (Baseline and After One Week of Product Use)</title>
        <description>Comparison of colposcopic findings between baseline visits and after one week of twice-daily application of Tenofovir 1% gel with either a user-filled or prefilled applicator</description>
        <time_frame>7 days</time_frame>
        <population>The number of participants for analysis was determined by counting the number of participants with colposcopic findings and baseline and after one week of product use.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline Colposcopic Findings</title>
            <description>Number of colposcopic findings identified during baseline colposcopies for both study arms. Note: Since a participant can have more than one colposcopic finding, the number of colposcopic findings does not necessarily equal the number of participants with colposcopic findings.</description>
          </group>
          <group group_id="O2">
            <title>Colposcopic Findings After 7 Days of Product Use</title>
            <description>Number of colposcopic findings identified during colposcopy after one week of twice daily product use (data from both study arms are combined). Note: Since a participant can have more than one colposcopic finding, the number of colposcopic findings does not necessarily equal the number of participants with colposcopic findings.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Colposcopic Findings (Baseline and After One Week of Product Use)</title>
          <description>Comparison of colposcopic findings between baseline visits and after one week of twice-daily application of Tenofovir 1% gel with either a user-filled or prefilled applicator</description>
          <population>The number of participants for analysis was determined by counting the number of participants with colposcopic findings and baseline and after one week of product use.</population>
          <units>colposcopic findings</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>colposcopic findings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Petechiae</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Laceration external genitalia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peeling cervic or vagina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Petechiae (iatrogenic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ecchymosis left lateral vaginal wall (iatrogenic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Fishers exact test was used to compare the frequency of non-iatrogenic colposcopic findings at baseline and follow-up visits (after one week of twice-daily product use).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4870</p_value>
            <p_value_desc>The p-value presented here represents a comparison of the total number of non-iatrogenic findings at baseline and after one week of product use.</p_value_desc>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting That They Would Use the User-filled Applicator in the Future if it Came With a Gel for HIV Prevention</title>
        <description>Participants were asked if they would use the user-filled applicator in the future if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Entire Study Population</title>
            <description>Includes groups randomized to use the prefilled applicator first and the user-filled applicator first.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting That They Would Use the User-filled Applicator in the Future if it Came With a Gel for HIV Prevention</title>
          <description>Participants were asked if they would use the user-filled applicator in the future if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>In some circumstances</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting That They Would Not Want to Use the User-filled Applicator in the Future if it Came With a Gel for HIV Prevention</title>
        <description>Participants were asked if there were any reasons that they would not want to use this user-filled applicator in the future if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Entire Study Population</title>
            <description>Includes groups randomized to use the prefilled applicator first and the user-filled applicator first.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting That They Would Not Want to Use the User-filled Applicator in the Future if it Came With a Gel for HIV Prevention</title>
          <description>Participants were asked if there were any reasons that they would not want to use this user-filled applicator in the future if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>In some circumstances</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting That They Would Recommend the User-filled Applicator for HIV Prevention</title>
        <description>Participants were asked if they would recommend the user-filled applicator to other women if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
        <time_frame>Final study visit (after completing both study arms)</time_frame>
        <population>All participants were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Entire Study Population</title>
            <description>Includes groups randomized to use the prefilled applicator first and the user-filled applicator first.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting That They Would Recommend the User-filled Applicator for HIV Prevention</title>
          <description>Participants were asked if they would recommend the user-filled applicator to other women if it came with a gel that helped prevent HIV infection.
Response categories included &quot;yes&quot;, &quot;no&quot;, and &quot;in some circumstances&quot;.</description>
          <population>All participants were included in the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>In some circumstances</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>Adverse events were collected for the entire study period: January 26, 2011, to June 10, 2011.</desc>
      <group_list>
        <group group_id="E1">
          <title>User-Filled Applicator</title>
          <description>paper applicator (filled using a tube of Tenofovir 1% gel)</description>
        </group>
        <group group_id="E2">
          <title>Prefilled Applicator</title>
          <description>plastic applicator (prefilled with Tenofovir 1% gel)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Tooth pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Common cold</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Investigators have agreed to provide drug sponsor with a copy of any draft manuscript or abstract for its review and comment at least thirty days prior to submission for publication and provide a copy of any draft presentation at least seven days in advance of any scientific meeting or conference.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Due to an error in the interpretation of the user instructions and resulting depth of plunger insertion into the barrel by the participants, the dose delivery data for the prefilled applicator were not valid.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jessica Cohen</name_or_title>
      <organization>PATH</organization>
      <phone>206-285-3500</phone>
      <email>jcohen@path.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

